Supplier
Ihc Health Services INC
Ihc Health Services INC was paid $6.51M by Medicaid between Jan 2018 and Nov 2024, across 4 billing codes. Its largest line is J7639, Dornase alfa, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram — 60% of everything it billed.
33Billing provider infoIHC HEALTH SERVICES INC
MIDVALE, UT 84047
MIDVALE, UT 84047
33aNPI1093130031assigned 02/27/2014
33bProvider typePharmacy
28Total paid$6.51M
24GClaims2,727
24DCodes billed4
24AFirst – last monthJan 2018 – Nov 2024
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 240 | $800K | |
| 2019 | 203 | $676K | |
| 2020 | 248 | $713K | |
| 2021 | 517 | $1.26M | |
| 2022 | 680 | $1.53M | |
| 2023 | 506 | $1.05M | |
| 2024incomplete | 333 | $485K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| J7639 | Dornase alfa, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram | 60% | 1,097 | 1,023 | $3.91M |
| J2357 | Injection, omalizumab, 5 mg | 22% | 639 | 561 | $1.43M |
| J0585 | Injection, onabotulinumtoxina, 1 unit | 18% | 973 | 947 | $1.17M |
| 90378 | <1% | 18 | 12 | $5K |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialBERENSEN, NANNETTE (VICE PRESIDENT OF CLINICAL SYSTEMS)
Parent organizationIHC HEALTH SERVICES INC
| Provider | Location | Paid |
|---|---|---|
| Ihc Health Services, INC. | Murray, UT | $5K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.